Treatment of schizophrenia and spectrum disorders: pharmacotherapy, psychosocial treatments, and neurotransmitter interactions

This publication has 27 references indexed in Scilit:

• The Role of Serotonin in Antipsychotic Drug Action
  Neuropsychopharmacology, 1999
• Cognitive improvement in schizophrenia with novel antipsychotic medications
  Schizophrenia Research, 1999
• Serotonin Subtype 2 Receptor Genes and Clinical Response to Clozapine in Schizophrenia Patients
  Neuropsychopharmacology, 1998
• Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
• The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
• Treatment-Resistant Schizophrenia - The Role of Clozapine
  Current Medical Research and Opinion, 1997
• Is it possible to be schizophrenic yet neuropsychologically normal?
  Neuropsychology, 1997
• The Effect of Clozapine and Other Atypical Antipsychotic Drugs on Negative Symptoms
  Published by Springer Nature ,1991
• Typical and atypical antipsychotic occupancy of D2 and S2 receptors: An autoradiographic analysis in rat brain
  Brain Research Bulletin, 1986
• Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain
  Acta Pharmacologica et Toxicologica, 1963